Comments
Loading...
Vigil Neuroscience (VIGL) Forecast
NewsEarningsVigil Neuroscience (VIGL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVigil Neuroscience (NASDAQ:VIGL) Stock Quotes, Forecast and News Summary
Vigil Neuroscience Stock (NASDAQ: VIGL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vigil Neuroscience (VIGL) stock?
You can purchase shares of Vigil Neuroscience (NASDAQ:VIGL) through any online brokerage.
Who are Vigil Neuroscience (VIGL) competitors?
Other companies in Vigil Neuroscience’s space includes: Renovaro (NASDAQ:RENB), Cabaletta Bio (NASDAQ:CABA), Anixa Biosciences (NASDAQ:ANIX), Skye Bioscience (NASDAQ:SKYE) and Atossa Therapeutics (NASDAQ:ATOS).
What is the forecast, or price target, for Vigil Neuroscience (VIGL) stock?
Vigil Neuroscience has a consensus price target of $15.83.
What is the current price for Vigil Neuroscience (VIGL)?
The stock price for Vigil Neuroscience (NASDAQ: VIGL) is $2.89 last updated February 21, 2025 at 9:02 AM EST.
Does Vigil Neuroscience (VIGL) pay a dividend?
There are no upcoming dividends for Vigil Neuroscience.
When is Vigil Neuroscience (NASDAQ:VIGL) reporting earnings?
Vigil Neuroscience’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Vigil Neuroscience (VIGL) going to split?
There is no upcoming split for Vigil Neuroscience.
What sector and industry does Vigil Neuroscience (VIGL) operate in?
Vigil Neuroscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.